Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
This report contains market size and forecasts of Argatroban in global, including the following market information:
Global Argatroban Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Argatroban Market Sales, 2017-2022, 2023-2028, (g)
Global top five Argatroban companies in 2021 (%)
The global Argatroban market was valued at 65 million in 2021 and is projected to reach US$ 44 million by 2028, at a CAGR of -5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Argatroban Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Argatroban include Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd and WEST-WARD,INC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Argatroban manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Argatroban Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Argatroban Market Segment Percentages, by Type, 2021 (%)
Argatroban Powder
Argatroban Injection
Global Argatroban Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Argatroban Market Segment Percentages, by Application, 2021 (%)
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Global Argatroban Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Argatroban Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Argatroban revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Argatroban revenues share in global market, 2021 (%)
Key companies Argatroban sales in global market, 2017-2022 (Estimated), (g)
Key companies Argatroban sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC